Collectively, these results revealed that miR-93-5p inhibited PPARGC1A and CDKN1A genes, thereby decreasing the expressions of transcription factors CEBPB and promoting hepatoma cells proliferation (Figure 5H). The gene discussed is CDKN1A; the disease is hepatocellular carcinoma.